Global Subcutaneous Biologics Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Driven by the downstream end-users, the market of Subcutaneous Biologics witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Subcutaneous Biologics market is offered. The research provides insights for the global Subcutaneous Biologics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Subcutaneous Biologics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Subcutaneous Biologics Market Segmentations:

    By Players:

    • Activa

    • CeQur SA

    • AstraZeneca

    • Aptar Pharm

    • Bioject Medical Technologies, Inc.

    • Advantage Health Services

    • Battelle

    • Abbott Laboratories

    • Alnylam Pharmaceuticals

    • Antares Pharma

    • Arte Corporation

    • Biogen Idec

    • Adamis Pharmaceuticals Corporation

    • Aradigm Corporation

    • Bespak

    • Calibra Medical

    • Aguettant

    • Ascendis Pharma

    • Ajinomoto Althea Inc.

    • Becton Dickinson

    • ADOCIA

    • Amgen

    • Bayer

    • Baxter

    • Bristol-Myers Squibb Co

    • Bang and Olufsen


    By Types:

    • Insulin Pumps with Infusion Sets

    • Insulin Patch Pumps

    • Transdermal Patch

    • Bolus Injectors


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Subcutaneous Biologics Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Subcutaneous Biologics Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Subcutaneous Biologics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Subcutaneous Biologics Market Share by Types

      • 1.3.2 Global Subcutaneous Biologics Market Size and Growth Rate of Insulin Pumps with Infusion Sets from 2013 to 2025

      • 1.3.3 Global Subcutaneous Biologics Market Size and Growth Rate of Insulin Patch Pumps from 2013 to 2025

      • 1.3.4 Global Subcutaneous Biologics Market Size and Growth Rate of Transdermal Patch from 2013 to 2025

      • 1.3.5 Global Subcutaneous Biologics Market Size and Growth Rate of Bolus Injectors from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Subcutaneous Biologics Market Share by End-Users

      • 1.4.2 Global Subcutaneous Biologics Market Size and Growth Rate of End-User 1 from 2013 to 2025

      • 1.4.3 Global Subcutaneous Biologics Market Size and Growth Rate of End-User 2 from 2013 to 2025

      • 1.4.4 Global Subcutaneous Biologics Market Size and Growth Rate of End-User 3 from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumSubcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Subcutaneous Biologics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Subcutaneous Biologics by Major Types

      • 3.4.1 Market Size and Growth Rate of Insulin Pumps with Infusion Sets

      • 3.4.2 Market Size and Growth Rate of Insulin Patch Pumps

      • 3.4.3 Market Size and Growth Rate of Transdermal Patch

      • 3.4.4 Market Size and Growth Rate of Bolus Injectors


    4 Segmentation of Subcutaneous Biologics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Subcutaneous Biologics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Subcutaneous Biologics for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Subcutaneous Biologics for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Subcutaneous Biologics for End-Users 3


    5 Market Analysis by Major Regions

    • 5.1 Global Subcutaneous Biologics Production Analysis by Major Regions

    • 5.2 Global Subcutaneous Biologics Consumption Analysis by Major Regions

    • 5.3 Global Subcutaneous Biologics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Subcutaneous Biologics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Subcutaneous Biologics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Subcutaneous Biologics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Subcutaneous Biologics Production, Import, Consumption and Export Analysis


    6 Product Commodity of Subcutaneous Biologics Market in Major Countries

    • 6.1 Top 5 Export Countries in Subcutaneous Biologics market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Subcutaneous Biologics market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Subcutaneous Biologics market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Subcutaneous Biologics market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Subcutaneous Biologics market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Subcutaneous Biologics market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Subcutaneous Biologics Landscape Analysis

    • 7.1 North America Subcutaneous Biologics Landscape Analysis by Major Types

    • 7.2 North America Subcutaneous Biologics Landscape Analysis by Major End-Users

    • 7.3 North America Subcutaneous Biologics Landscape Analysis by Major Countries

      • 7.3.1 United States Subcutaneous Biologics Market Volume and Growth Rate

      • 7.3.2 Canada Subcutaneous Biologics Market Volume and Growth Rate

      • 7.3.3 Mexico Subcutaneous Biologics Market Volume and Growth Rate


    8 Europe Subcutaneous Biologics Landscape Analysis

    • 8.1 Europe Subcutaneous Biologics Landscape Analysis by Major Types

    • 8.2 Europe Subcutaneous Biologics Landscape Analysis by Major End-Users

    • 8.3 Europe Subcutaneous Biologics Landscape Analysis by Major Countries

      • 8.3.1 Germany Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.2 UK Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.3 France Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.4 Italy Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.6 Spain Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.7 Belgium Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.8 Poland Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.9 Russia Subcutaneous Biologics Market Volume and Growth Rate

      • 8.3.10 Turkey Subcutaneous Biologics Market Volume and Growth Rate


    9 Asia Pacific Subcutaneous Biologics Landscape Analysis

    • 9.1 Asia Pacific Subcutaneous Biologics Landscape Analysis by Major Types

    • 9.2 Asia Pacific Subcutaneous Biologics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Subcutaneous Biologics Landscape Analysis by Major Countries

      • 9.3.1 China Subcutaneous Biologics Market Volume and Growth Rate

      • 9.3.2 Japan Subcutaneous Biologics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Subcutaneous Biologics Market Volume and Growth Rate

      • 9.3.4 India Subcutaneous Biologics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Subcutaneous Biologics Market Volume and Growth Rate

      • 9.3.6 South Korea Subcutaneous Biologics Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Subcutaneous Biologics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Subcutaneous Biologics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Subcutaneous Biologics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Subcutaneous Biologics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Subcutaneous Biologics Market Volume and Growth Rate

      • 10.3.2 Brazil Subcutaneous Biologics Market Volume and Growth Rate

      • 10.3.3 Nigeria Subcutaneous Biologics Market Volume and Growth Rate

      • 10.3.4 South Africa Subcutaneous Biologics Market Volume and Growth Rate 

      • 10.3.5 Argentina Subcutaneous Biologics Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Activa

      • 11.1.1 Activa Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 CeQur SA

      • 11.2.1 CeQur SA Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 AstraZeneca

      • 11.3.1 AstraZeneca Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Aptar Pharm

      • 11.4.1 Aptar Pharm Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Bioject Medical Technologies, Inc.

      • 11.5.1 Bioject Medical Technologies, Inc. Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Advantage Health Services

      • 11.6.1 Advantage Health Services Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Battelle

      • 11.7.1 Battelle Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Abbott Laboratories

      • 11.8.1 Abbott Laboratories Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Alnylam Pharmaceuticals

      • 11.9.1 Alnylam Pharmaceuticals Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Antares Pharma

      • 11.10.1 Antares Pharma Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Arte Corporation

      • 11.11.1 Arte Corporation Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Biogen Idec

      • 11.12.1 Biogen Idec Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Adamis Pharmaceuticals Corporation

      • 11.13.1 Adamis Pharmaceuticals Corporation Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Aradigm Corporation

      • 11.14.1 Aradigm Corporation Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Bespak

      • 11.15.1 Bespak Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Calibra Medical

      • 11.16.1 Calibra Medical Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Aguettant

      • 11.17.1 Aguettant Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Ascendis Pharma

      • 11.18.1 Ascendis Pharma Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Ajinomoto Althea Inc.

      • 11.19.1 Ajinomoto Althea Inc. Company Profile and Development Status

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Becton Dickinson

      • 11.20.1 Becton Dickinson Company Profile and Development Status

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    • 11.21 ADOCIA

      • 11.21.1 ADOCIA Company Profile and Development Status

      • 11.21.2 Market Performance

      • 11.21.3 Product and Service Introduction

    • 11.22 Amgen

      • 11.22.1 Amgen Company Profile and Development Status

      • 11.22.2 Market Performance

      • 11.22.3 Product and Service Introduction

    • 11.23 Bayer

      • 11.23.1 Bayer Company Profile and Development Status

      • 11.23.2 Market Performance

      • 11.23.3 Product and Service Introduction

    • 11.24 Baxter

      • 11.24.1 Baxter Company Profile and Development Status

      • 11.24.2 Market Performance

      • 11.24.3 Product and Service Introduction

    • 11.25 Bristol-Myers Squibb Co

      • 11.25.1 Bristol-Myers Squibb Co Company Profile and Development Status

      • 11.25.2 Market Performance

      • 11.25.3 Product and Service Introduction

    • 11.26 Bang and Olufsen

      • 11.26.1 Bang and Olufsen Company Profile and Development Status

      • 11.26.2 Market Performance

      • 11.26.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 80 Figures and 132 Tables)

    • Figure Product Picture

    • Figure Global Subcutaneous Biologics Market Size and Growth Rate of Insulin Pumps with Infusion Sets from 2013 to 2025

    • Figure Global Subcutaneous Biologics Market Size and Growth Rate of Insulin Patch Pumps from 2013 to 2025

    • Figure Global Subcutaneous Biologics Market Size and Growth Rate of Transdermal Patch from 2013 to 2025

    • Figure Global Subcutaneous Biologics Market Size and Growth Rate of Bolus Injectors from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Subcutaneous Biologics Market Size and Growth Rate of End-User 1 from 2013 to 2025

    • Figure Global Subcutaneous Biologics Market Size and Growth Rate of End-User 2 from 2013 to 2025

    • Figure Global Subcutaneous Biologics Market Size and Growth Rate of End-User 3 from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Subcutaneous Biologics Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Subcutaneous Biologics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Subcutaneous Biologics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Subcutaneous Biologics by Different Types from 2013 to 2025

    • Table Consumption Share of Subcutaneous Biologics by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of Insulin Pumps with Infusion Sets

    • Figure Market Size and Growth Rate of Insulin Patch Pumps

    • Figure Market Size and Growth Rate of Transdermal Patch

    • Figure Market Size and Growth Rate of Bolus Injectors

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Subcutaneous Biologics by Different End-Users from 2013 to 2025

    • Table Consumption Share of Subcutaneous Biologics by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Global Subcutaneous Biologics Production by Major Regions

    • Table Global Subcutaneous Biologics Production Share by Major Regions

    • Figure Global Subcutaneous Biologics Production Share by Major Regions in 2013

    • Figure Global Subcutaneous Biologics Production Share by Major Regions in 2018

    • Figure Global Subcutaneous Biologics Production Share by Major Regions in 2025

    • Table Global Subcutaneous Biologics Consumption by Major Regions

    • Table Global Subcutaneous Biologics Consumption Share by Major Regions

    • Figure Global Subcutaneous Biologics Consumption Share by Major Regions in 2013

    • Figure Global Subcutaneous Biologics Consumption Share by Major Regions in 2018

    • Figure Global Subcutaneous Biologics Consumption Share by Major Regions in 2025

    • Table North America Subcutaneous Biologics Production, Import, Consumption and Export Analysis

    • Table Europe Subcutaneous Biologics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Subcutaneous Biologics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Subcutaneous Biologics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Subcutaneous Biologics market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Subcutaneous Biologics market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Subcutaneous Biologics market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Subcutaneous Biologics market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Subcutaneous Biologics Consumption by Types from 2013 to 2025

    • Table North America Subcutaneous Biologics Consumption Share by Types from 2013 to 2025

    • Figure North America Subcutaneous Biologics Consumption Share by Types in 2013

    • Figure North America Subcutaneous Biologics Consumption Share by Types in 2018

    • Figure North America Subcutaneous Biologics Consumption Share by Types in 2025

    • Table North America Subcutaneous Biologics Consumption by End-Users from 2013 to 2025

    • Table North America Subcutaneous Biologics Consumption Share by End-Users from 2013 to 2025

    • Figure North America Subcutaneous Biologics Consumption Share by End-Users in 2013

    • Figure North America Subcutaneous Biologics Consumption Share by End-Users in 2018

    • Figure North America Subcutaneous Biologics Consumption Share by End-Users in 2025

    • Table North America Subcutaneous Biologics Consumption by Major Countries from 2013 to 2025

    • Table North America Subcutaneous Biologics Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Subcutaneous Biologics Consumption Share by Major Countries in 2013

    • Figure North America Subcutaneous Biologics Consumption Share by Major Countries in 2018

    • Figure North America Subcutaneous Biologics Consumption Share by Major Countries in 2025

    • Figure United States Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Subcutaneous Biologics Consumption by Types from 2013 to 2025

    • Table Europe Subcutaneous Biologics Consumption Share by Types from 2013 to 2025

    • Figure Europe Subcutaneous Biologics Consumption Share by Types in 2013

    • Figure Europe Subcutaneous Biologics Consumption Share by Types in 2018

    • Figure Europe Subcutaneous Biologics Consumption Share by Types in 2025

    • Table Europe Subcutaneous Biologics Consumption by End-Users from 2013 to 2025

    • Table Europe Subcutaneous Biologics Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Subcutaneous Biologics Consumption Share by End-Users in 2013

    • Figure Europe Subcutaneous Biologics Consumption Share by End-Users in 2018

    • Figure Europe Subcutaneous Biologics Consumption Share by End-Users in 2025

    • Table Europe Subcutaneous Biologics Consumption by Major Countries from 2013 to 2025

    • Table Europe Subcutaneous Biologics Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Subcutaneous Biologics Consumption Share by Major Countries in 2013

    • Figure Europe Subcutaneous Biologics Consumption Share by Major Countries in 2018

    • Figure Europe Subcutaneous Biologics Consumption Share by Major Countries in 2025

    • Figure Germany Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure France Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Subcutaneous Biologics Consumption by Types from 2013 to 2025

    • Table Asia Pacific Subcutaneous Biologics Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by Types in 2013

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by Types in 2018

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by Types in 2025

    • Table Asia Pacific Subcutaneous Biologics Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Subcutaneous Biologics Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by End-Users in 2013

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by End-Users in 2018

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by End-Users in 2025

    • Table Asia Pacific Subcutaneous Biologics Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Subcutaneous Biologics Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Subcutaneous Biologics Consumption Share by Major Countries in 2025

    • Figure China Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandSubcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure India Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Subcutaneous Biologics Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Subcutaneous Biologics Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Subcutaneous Biologics Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Subcutaneous Biologics Consumption Share by Major Countries in 2025

    • Figure GCC Countries Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Subcutaneous Biologics Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of Activa

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Activa

    • Figure Sales and Growth Rate Analysis of Activa

    • Figure Revenue and Market Share Analysis of Activa

    • Table Product and Service Introduction of Activa

    • Table Company Profile and Development Status of CeQur SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CeQur SA

    • Figure Sales and Growth Rate Analysis of CeQur SA

    • Figure Revenue and Market Share Analysis of CeQur SA

    • Table Product and Service Introduction of CeQur SA

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Aptar Pharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aptar Pharm

    • Figure Sales and Growth Rate Analysis of Aptar Pharm

    • Figure Revenue and Market Share Analysis of Aptar Pharm

    • Table Product and Service Introduction of Aptar Pharm

    • Table Company Profile and Development Status of Bioject Medical Technologies, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bioject Medical Technologies, Inc.

    • Figure Sales and Growth Rate Analysis of Bioject Medical Technologies, Inc.

    • Figure Revenue and Market Share Analysis of Bioject Medical Technologies, Inc.

    • Table Product and Service Introduction of Bioject Medical Technologies, Inc.

    • Table Company Profile and Development Status of Advantage Health Services

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advantage Health Services

    • Figure Sales and Growth Rate Analysis of Advantage Health Services

    • Figure Revenue and Market Share Analysis of Advantage Health Services

    • Table Product and Service Introduction of Advantage Health Services

    • Table Company Profile and Development Status of Battelle

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Battelle

    • Figure Sales and Growth Rate Analysis of Battelle

    • Figure Revenue and Market Share Analysis of Battelle

    • Table Product and Service Introduction of Battelle

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of Antares Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antares Pharma

    • Figure Sales and Growth Rate Analysis of Antares Pharma

    • Figure Revenue and Market Share Analysis of Antares Pharma

    • Table Product and Service Introduction of Antares Pharma

    • Table Company Profile and Development Status of Arte Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arte Corporation

    • Figure Sales and Growth Rate Analysis of Arte Corporation

    • Figure Revenue and Market Share Analysis of Arte Corporation

    • Table Product and Service Introduction of Arte Corporation

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of Adamis Pharmaceuticals Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adamis Pharmaceuticals Corporation

    • Figure Sales and Growth Rate Analysis of Adamis Pharmaceuticals Corporation

    • Figure Revenue and Market Share Analysis of Adamis Pharmaceuticals Corporation

    • Table Product and Service Introduction of Adamis Pharmaceuticals Corporation

    • Table Company Profile and Development Status of Aradigm Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aradigm Corporation

    • Figure Sales and Growth Rate Analysis of Aradigm Corporation

    • Figure Revenue and Market Share Analysis of Aradigm Corporation

    • Table Product and Service Introduction of Aradigm Corporation

    • Table Company Profile and Development Status of Bespak

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bespak

    • Figure Sales and Growth Rate Analysis of Bespak

    • Figure Revenue and Market Share Analysis of Bespak

    • Table Product and Service Introduction of Bespak

    • Table Company Profile and Development Status of Calibra Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calibra Medical

    • Figure Sales and Growth Rate Analysis of Calibra Medical

    • Figure Revenue and Market Share Analysis of Calibra Medical

    • Table Product and Service Introduction of Calibra Medical

    • Table Company Profile and Development Status of Aguettant

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aguettant

    • Figure Sales and Growth Rate Analysis of Aguettant

    • Figure Revenue and Market Share Analysis of Aguettant

    • Table Product and Service Introduction of Aguettant

    • Table Company Profile and Development Status of Ascendis Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ascendis Pharma

    • Figure Sales and Growth Rate Analysis of Ascendis Pharma

    • Figure Revenue and Market Share Analysis of Ascendis Pharma

    • Table Product and Service Introduction of Ascendis Pharma

    • Table Company Profile and Development Status of Ajinomoto Althea Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ajinomoto Althea Inc.

    • Figure Sales and Growth Rate Analysis of Ajinomoto Althea Inc.

    • Figure Revenue and Market Share Analysis of Ajinomoto Althea Inc.

    • Table Product and Service Introduction of Ajinomoto Althea Inc.

    • Table Company Profile and Development Status of Becton Dickinson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton Dickinson

    • Figure Sales and Growth Rate Analysis of Becton Dickinson

    • Figure Revenue and Market Share Analysis of Becton Dickinson

    • Table Product and Service Introduction of Becton Dickinson

    • Table Company Profile and Development Status of ADOCIA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ADOCIA

    • Figure Sales and Growth Rate Analysis of ADOCIA

    • Figure Revenue and Market Share Analysis of ADOCIA

    • Table Product and Service Introduction of ADOCIA

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of Bristol-Myers Squibb Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Co

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Co

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Co

    • Table Product and Service Introduction of Bristol-Myers Squibb Co

    • Table Company Profile and Development Status of Bang and Olufsen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bang and Olufsen

    • Figure Sales and Growth Rate Analysis of Bang and Olufsen

    • Figure Revenue and Market Share Analysis of Bang and Olufsen

    • Table Product and Service Introduction of Bang and Olufsen


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.